Exelixis | EXEL - Pe Prix À Revenus

Prix De L'Action
44.94
Variation Quotidienne
-1.11 -2.41%
Mensuellement
5.04%
Annuel
20.06%
Q2 Prévisions
43.98




Pe Changement Date
Acadia Pharmaceuticals 11.61 2.09 2025-12
Agios Pharmaceuticals 3.56 0.68 2025-09
Akebia Therapeutics 1.63K 1.6K 2025-12
Amgen 25.31 15.82 2025-12
AstraZeneca 27.29 5.8 2025-12
Bayer 5.93 0.68 2025-09
BioMarin Pharmaceutical 19.24 0.21 2025-12
Bristol-Myers Squibb 9.28 1.04 2025-12
Eisai 26.63 0.46 2025-12
Eli Lilly 40.21 9.66 2025-12
Esperion Therapeutics 129.79 129 2024-12
Exelixis 602.31 586.25 2025-12
Genmab 17.14 4.39 2025-12
Glaxosmithkline 11.66 0.28 2025-12
Incyte 14.84 2.79 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Merck 13.92 5.08 2025-12
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 835.47 802.2 2025-12
Novartis 17.85 2.11 2025-12
Pfizer 14.48 5.18 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Sanofi 15.75 1.53 2025-12
Takeda 235.05 184.95 2025-12
Xencor 29.92 3.22 2022-09